Spectral Medical Inc T.EDT

This line says it all...

[mercedesman]

“We are maintaining our Buy rating but lowering our target to $2.10 (was $2.40) mainly owing to increasing our assumed dilution from additional financings,” McAuley said.


Talk about conflicting objectives !  Drag your feet and secure a much bigger peice of the pie, or just get'er done?

MM

[Domino55]

If anybody but you pointed that out they would attacked but your buddy!  Hopefully they sell to Baxter before that becomes necessary.

[PezDalatoYou]

Ok I will address the elephant in the room. (I've got buddy on ignore). There are new details in the Paradigm update that we have not heard from Spectral itself. I don't recall anyway...The most concerning detail is 'internal restructuring'. Most likely this is the cause of the trial delays. Have we been told about this officially? 'Blame covid' instead. We also have

[Accountprince]

MM thanks for your astute observations.  Paradigm seems to be grinding down their valuation as time drags on.  I don't understand their rationale unless they have some other incentive to do so. When Paradigm did their $4 per share value fully diluted shares were 269 million.  The recent presentation from Spectral shows fully diluted shares at 305.5 million.  So have we

[mercedesman]

Thx AP I'll come out of my self imposed exile, when-ever I see an intelligent post surface, such as yours. "So in spite of the trials being behind I think their progress adds value that more than compensates for a 15% dilution.  Perhaps that is why the BoD handed out the party favors so generously recently. The opposite of that is if the BoD and management truly felt we'd lost

[MMABStrader]

MM, I agree with almost everything you said in your post. But what I think you and others don't understand is that Paradigm's price target of $2.10 means it is the forecasted price/anticipated price/guestimated share price sometime in the next 12 months.  I'm sure they don't think this is the highest price Spectral will ever achieve, or an end game/buy out price.  I

[Domino55]

MMA- I agree with most of what you said, although I would not necessarily, INMHO, count on Paradigm being an honest broker. They may have an agenda different from the small retail holdings. taking highly dilutive financings and giving zero, absolutely MOFO ZERO,support afterwards-that hasn't gone unnoticed. Shareholders are aware of the analyst/management ties. Yes the analyst article was on

[Accountprince]

MMABStrader - you are precisely the kind of investor their current game loves.  Would you be happy if they said $0.30US or $0.50US or even $0.90US per share?  How happy are you that you've been diluted by 15% over 2 years while management and a select group have accumulated huge positions including warrants and options that provide zero funds to the company?  How happy are you

[MMABStrader]

Accountprince...  Your head and my head are in two different places.  I think the glass is half full and you think it's half empty.  I think your response to my post was a bunch of jibberish. Yes, I have been disappointed by the delays in the PMX and the DIMI trials. But I think the end game will be rewarding for all Spectral shareholders. Yes, it's disappointing that U.S.